节点文献

经皮穴位电刺激治疗女性慢性盆腔痛及痛经的初步探讨

Transcutaneous electrical acupoint stimulation in the treatment of chronic pelvic pain and dysmenorrhea in female patients:a pilot trial

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 金莹郭红燕贺豪杰韩劲松朱馥丽梁华茂孔东丽

【Author】 JIN Ying;GUO Hongyan;HE Haojie;HAN Jinsong;ZHU Fuli;LIANG Huamao;KONG Dongli;Department of Obstetrics and Gynecology,Peking University Third Hospital;

【机构】 北京大学第三医院妇产科

【摘要】 目的探讨经皮穴位电刺激治疗女性慢性盆腔痛及痛经的疗效。方法 52例慢性盆腔痛或痛经患者,每周进行1次经皮穴位电刺激治疗,8次为一疗程。疼痛程度的量化标准采用视觉模拟评分法(visual analogue scoring,VAS),评价治疗前后患者的疼痛评分及生活质量的评分变化,并随访至治疗结束后2个月。结果 52例患者治疗前的疼痛VAS评分为(6.1±1.7)分,高于治疗结束时(3.1±1.3)分、治疗结束后1个月为(3.1±1.1)分及治疗结束后2个月为(3.4±1.0)分,差异有统计学意义(P值分别为0.034、0.045、0.019)。治疗结束时,治愈率15.4%(8/52)、有效率76.9%(40/52)、无效率7.7%(4/52)。治疗结束后1个月,8例治愈的患者中5例再次疼痛,40例治疗有效的患者中1例疼痛进展。治疗结束后2个月患者的疗效与治疗结束后1个月相比无明显变化。无效组患者治疗前的疼痛评分(8.3±2.2)分高于治愈组(5.1±0.8)分及有效组(6.1±1.6)分,差异有统计学意义(P值分别为0.041、0.026)。患者治疗结束后的生活质量评分高于治疗前,差异有统计学意义(P<0.05)。所有患者治疗过程中均未出现严重的不良反应。结论经皮穴位电刺激能显著地改善女性慢性盆腔痛或痛经患者的疼痛评分及生活质量评分,且无严重的不良反应。治疗效果与患者治疗前的疼痛评分相关,治疗结束后的长期疗效仍有待探讨。

【Abstract】 Objective To evaluate the effect of transcutaneous electrical acupoint stimulation(TEAS)in treating chronic pelvic pain and dysmenorrhea in female patients. Methods Fifty-two women diagnosed with chronic pelvic pain or dysmenorrhea were enrolled. Treatment was designed as TEAS once a week,eight weeks as a course. Pain was measured by VAS(visual analogue scoring).All patient filled out short form 36 questionare to value their quality of life. VAS scores and life quality scores were recorded before and after treatment. The follow up time was 2 months. Results Average VAS before TEAS was(6.1±1.7),which was significantly reduced after treatment(3.1±1.3),and remained constant one month(3.1±1.1)and two months after treatment(3.4±1.0).After one course of TEAS,15.4%(8/52)had complete remission(CR),76.9%(40/52)experienced partial symptom control(partial response,PR)and 7.7%(4/52)had no improvement(non-response,NR).Follow up at one month,five patients of the CR group and one patient of the PR group experienced pain relapse. Follow up at two months showed no change in symptoms in all patients. VAS before treatment was significantly different in three groups,with NR group(8.3±2.2)the highest,followed by the PR group(6.1±1.6)and the lowest in the CR group(5.1±0.8).The quality of life of all patients was improved which shown by higher life quality scores. No severe adverse effects were observed in all cases. Conclusions TEAS is a well-tolerated treatment modality which can markedly alleviate the symptoms of chronic pelvic pain and dysmenorrhea,and reduce their detrimental effects on patients’ daily life. VAS before treatment is associated withresponse to TEAS. Our study calls for research in the long-term efficacy of TEAS.

  • 【文献出处】 中国妇产科临床杂志 ,Chinese Journal of Clinical Obstetrics and Gynecology , 编辑部邮箱 ,2015年05期
  • 【分类号】R711
  • 【被引频次】16
  • 【下载频次】363
节点文献中: 

本文链接的文献网络图示:

本文的引文网络